User profiles for M. Hew

Mark Hew

Head of Allergy, Asthma & Clinical Immunology, Alfred Health
Verified email at alfred.org.au
Cited by 8199

Comorbid “treatable traits” in difficult asthma: current evidence and clinical evaluation

TR Tay, M Hew - Allergy, 2018 - Wiley Online Library
The care of patients with difficult‐to‐control asthma (“difficult asthma”) is challenging and
costly. Despite high‐intensity asthma treatment, these patients experience poor asthma control …

Oral corticosteroids stewardship for asthma in adults and adolescents: a position paper from the Thoracic Society of Australia and New Zealand

…, S Bosnic‐Anticevich, J Harrington, M Hew… - …, 2021 - Wiley Online Library
Oral corticosteroids (OCS) are frequently used for asthma treatment. This medication is highly
effective for both acute and chronic diseases, but evidence indicates that indiscriminate …

Recent developments and highlights in biomarkers in allergic diseases and asthma

I Eguiluz‐Gracia, TR Tay, M Hew, MM Escribese… - Allergy, 2018 - Wiley Online Library
The potential of precision medicine in allergy and asthma has only started to be explored. A
significant clarification in the pathophysiology of rhinitis, chronic rhinosinusitis, asthma, food …

Characterization of the severe asthma phenotype by the national heart, lung, and blood institute's severe asthma research program

…, RA Dweik, AM Fitzpatrick, B Gaston, M Hew… - Journal of Allergy and …, 2007 - Elsevier
BACKGROUND: Severe asthma causes the majority of asthma morbidity. Understanding
mechanisms that contribute to the development of severe disease is important. OBJECTIVE: …

Increased expression of transient receptor potential vanilloid-1 in airway nerves of chronic cough

…, A Niimi, QT Dinh, B Cosio, M Hew… - American journal of …, 2004 - atsjournals.org
Transient receptor potential vanniloid-1 (TRPV-1) mediates the cough response induced by
the pepper extract capsaicin and is expressed in sensory nerves that innervate the airway …

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

…, P Thomas, P Bardin, D Sajkov, M Hew… - The lancet respiratory …, 2019 - thelancet.com
… No new consequences of long-term eosinophil depletion occurred, and the incidence of
other adverse events, including opportunistic infections, were similar during the second year. …

Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma

M Hew, P Bhavsar, A Torrego, S Meah… - American journal of …, 2006 - atsjournals.org
… We showed that at the higher dose of 10 −6 M of dexamethasone, there was less reduction
of cytokine release in cells from patients with severe asthma compared that from patients with …

Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma

P Bhavsar, M Hew, N Khorasani, A Torrego, PJ Barnes… - Thorax, 2008 - thorax.bmj.com
… Figure 2 Effect of (A) dexamethasone 10 −6 M and (B) dexamethasone 10 −8 M on the
suppression of release of 10 cytokines from alveolar macrophages stimulated by …

[HTML][HTML] Characterization of severe asthma worldwide: data from the International Severe Asthma Registry

…, PG Gibson, M Hew, M Peters, ES Harvey, M Alacqua… - Chest, 2020 - Elsevier
Background Clinical characteristics of the international population with severe asthma are
unknown. Intercountry comparisons are hindered by variable data collection within regional …

[HTML][HTML] The Melbourne epidemic thunderstorm asthma event 2016: an investigation of environmental triggers, effect on health services, and patient risk factors

…, PJ Beggs, D Csutoros, J Darvall, M Hew… - The Lancet Planetary …, 2018 - thelancet.com
Background A multidisciplinary collaboration investigated the world's largest, most catastrophic
epidemic thunderstorm asthma event that took place in Melbourne, Australia, on Nov 21, …